Wednesday, August 24, 2016

AstraZeneca to sell antibiotics business to Pfizer

LONDON, Aug 24 (Reuters) - Pharmaceutical company

AstraZeneca said it had agreed to sell its small

molecule antibiotics business to Pfizer in a deal that

could reach more than $1.5 billion.

Read more

No comments:

Post a Comment